Document is current

Any future updates will be listed below

Promising results with zongertinib in advanced-stage HER2-mutant NSCLC

Crossref DOI link: https://doi.org/10.1038/s41571-025-01030-0

Published Online: 2025-05-13

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark